50 results
S-1
EX-3.3
INFIQ
Infinity Pharmaceuticals, Inc.
9 May 00
IPO registration
12:00am
duties as are incident to such office or are
properly required by the Board of Directors.
Section 7. Vice President. In the absence … and perform such other
duties as are incident to such office, or as are properly required by the
President or by the Board of Directors
S-3/A
EX-1.1
INFIQ
Infinity Pharmaceuticals, Inc.
4 May 04
Shelf registration (amended)
12:00am
with the Underwriters to pay (a) the costs incident to the authorization, issuance, sale, preparation and delivery of the Stock and any taxes payable … in that connection; (b) the costs incident to the registration of the Stock under the Securities Act; (c) the costs incident to the preparation, printing
8-K
EX-1.1
INFIQ
Infinity Pharmaceuticals, Inc.
13 Dec 12
Infinity Prices Public Offering of Common Stock
12:00am
contemplated in this Agreement are consummated or this Agreement is terminated, to pay or cause to be paid all expenses incident to the performance of its … incident to listing the Shares on the NASDAQ Global Select Market, (vi) the cost of printing certificates representing the Shares, (vii) the costs
8-K
EX-1.1
INFIQ
Infinity Pharmaceuticals, Inc.
10 Aug 12
Infinity Prices Public Offering of Common Stock
12:00am
in this Agreement are consummated or this Agreement is terminated, to pay or cause to be paid all expenses incident to the performance of its … incident to listing the Shares on the NASDAQ Global Select Market, (vi) the cost of printing certificates representing the Shares, (vii) the costs
8-K
EX-1.1
xymklg1xd3bi4y1hns
12 Apr 13
Infinity Announces Proposed Secondary Offering of Common Stock
12:00am
8-K
EX-1.1
1tfwn5i6sh9ffwk
12 Feb 21
Infinity Announces Proposed Public Offering of Common Stock
4:44pm
8-K
EX-1.1
7bzmucdn2u5
28 Jun 19
Entry into a Material Definitive Agreement
4:26pm
8-K
EX-1.1
y19mjlhb0jfi
30 Jul 19
Infinity Pharmaceuticals Provides Company Update and Second Quarter 2019 Financial Results
7:35am
8-K
EX-10.37
5f53iv
18 Sep 06
Infinity Pharmaceuticals Announces Completion of Merger with Discovery Partners International
12:00am
DEF 14A
tz9dbi3 nc9ut
10 Apr 01
Definitive proxy
12:00am
8-K
EX-2.1
oda4py nn
26 Jan 01
Current report
12:00am
S-1
EX-10.39
nax8ljmue8xnjjb2u
9 May 00
IPO registration
12:00am
S-1/A
EX-10.39
0gcygd3
23 Jun 00
IPO registration (amended)
12:00am